Euroopa Liit - malta - EMA (European Medicines Agency)

bluebird bio (netherlands) b.v. - awtologi taċ-ċelluli cd34+ arrikkit-popolazzjoni li fiha l-trapjant ta ' ċelloli staminali transduced mal-lentiglobin bb305 lentiviral vector kodifikazzjoni il-beta-a-t87q-emoglobina ġene - beta-talassimja - other hematological agents - zynteglo huwa indikat għall-kura tal-pazjenti ta'12-il sena u akbar bi dipendenti mit-trasfużjoni β-talessimja (tdt) li ma jkollhomx β0/β0-ġenotip, li għalihom il-ċelluli staminali ematopojetiċi (hsc) trapjant huwa xieraq iżda tal-lewkoċiti tal-bniedem l-antiġen (hla) mqabbla relatati hsc tad-donaturi mhux disponibbli.

Euroopa Liit - malta - EMA (European Medicines Agency)

ablynx nv - caplacizumab - purpura, purpura - aġenti antitrombotiċi - cablivi huwa indikat għall-kura ta ' adulti li qegħdin jesperjenzaw episodju ta miksuba purpura tromboċitopenika trombotika (attp), flimkien mal-plażma tal-kambju u l-immunosoppressjoni.

Euroopa Liit - malta - EMA (European Medicines Agency)

janssen-cilag international n.v. - palmpalidone palmitate - skizofrenija - psikolettiċi - xeplion huwa indikat għal trattament ta 'manteniment ta' skiżofrenja f'pazjenti adulti stabilizzati b'paliperidone jew risperidone. in selected adult patients with schizophrenia and previous responsiveness to oral paliperidone or risperidone, xeplion may be used without prior stabilisation with oral treatment if psychotic symptoms are mild to moderate and a long-acting injectable treatment is needed.

Euroopa Liit - malta - EMA (European Medicines Agency)

merck europe b.v.  - follitropin alfa, lutropin alfa - infertilità, mara - - ormoni tas-sess u modulaturi ta ' l-ġenitali-sistema, - pergoveris huwa indikat għall-istimulazzjoni ta ' l-iżvilupp follikulari fin-nisa bi problemi severi lutejniku-hormone (lh) u l-follikulu li jistimula l-ormon tat -. fi provi kliniċi, dawn il-pazjenti ġew definiti bil-livelli endoġeni tas-serum lh < 1. 2 iu / l.

Euroopa Liit - malta - EMA (European Medicines Agency)

bluebird bio (netherlands) b.v. - elivaldogene autotemcel - adrenoleukodystrophy - drogi oħra tas-sistema nervuża - treatment of early cerebral adrenoleukodystrophy in patients less than 18 years of age, with an abcd1 genetic mutation, and for whom a human leukocyte antigen (hla) matched sibling haematopoietic stem cell donor is not available.

Euroopa Liit - malta - EMA (European Medicines Agency)

substipharm - prasugrel - acute coronary syndrome; angina, unstable; myocardial infarction - aġenti antitrombotiċi - efient, ko amministrati bl-aċidu aċetilsaliċiliku (asa), huwa indikat għall-prevenzjoni ta ' avvenimenti ta ' atherothrombotic fil-pazjenti bl-sindromu coronary akuta (i. anġina instabbli, mhux-st-segment-elevazzjoni myocardial infarzjoni [ua / nstemi] jew st-segment-elevazzjoni myocardial infarzjoni [stemi]) li jkunu għaddejjin minn intervent coronary perkutanja (pci) ta ' primarja jew mdewma.

Euroopa Liit - malta - EMA (European Medicines Agency)

stada arzneimittel ag - teriparatide - l-osteoporożi - homeostasi tal-kalċju - movymia huwa indikat fl-adulti. trattament ta 'l-osteoporożi f'nisa wara l-menopawża u fl-irġiel b'riskju akbar ta' ksur. f'nisa wara l-menopawża, intwera tnaqqis sinifikanti fl-inċidenza ta 'ksur vertebrali u mhux vertebrali iżda mhux fratturi tal-ġenbejn. trattament ta 'osteoporożi assoċjat ma sostnut sistemika terapija bi glukokortikojdi f'nisa u l-irġiel f'riskju akbar ta' ksur.

Euroopa Liit - malta - EMA (European Medicines Agency)

gedeon richter plc. - teriparatide - l-osteoporożi - homeostasi tal-kalċju - terrosa hija indikata fl-adulti. trattament ta 'l-osteoporożi f'nisa wara l-menopawża u fl-irġiel b'riskju akbar ta' ksur. f'nisa wara l-menopawża, intwera tnaqqis sinifikanti fl-inċidenza ta 'ksur vertebrali u mhux vertebrali iżda mhux fratturi tal-ġenbejn. trattament ta 'osteoporożi assoċjat ma sostnut sistemika terapija bi glukokortikojdi f'nisa u l-irġiel f'riskju akbar ta' ksur.

Euroopa Liit - malta - EMA (European Medicines Agency)

janssen-cilag international n.v.   - palmpalidone palmitate - skizofrenija - psikolettiċi - byannli (previously paliperidone janssen-cilag international) a 6 monthly injection, is indicated for the maintenance treatment of schizophrenia in adult patients who are clinically stable on 1 monthly or 3 monthly paliperidone palmitate injectable products (see section 5.

Euroopa Liit - malta - EMA (European Medicines Agency)

astrazeneca ab - acalabrutinib - lewkimja, linfokitika, kronika, b-Ċellula - antineoplastic agents, protein kinase inhibitors, - calquence as monotherapy or in combination with obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll). calquence as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukaemia (cll) who have received at least one prior therapy.